Annualized average medical costs were estimated by phases of care: initial (first year after diagnosis), end-of-life (year before cancer death) and continuing (the time in between). Per-patient annualized average cancer-attributable costs were estimated, respectively, from 2007-2013 Medicare claims by subtracting costs between patients with cancer and their matched controls without cancer.All cost estimates have been adjusted and are reported in 2020 U.S.
#Average american finances 2015 update#
(1) and are an extension and update of previous estimates (2). The estimates in this report come from Mariotto, et al.Annualized average costs also varied by stage in all phases of care. Annualized average oral drug costs were highest for chronic myeloid leukemia (CML) and myeloma in all phases of care. There was considerable variation in costs by cancer site. If cancer diagnosis and treatment is divided into phases of care: initial (first year after diagnosis), end-of-life (year before cancer death) and continuing (the time in between), per-patient annualized average costs were highest in the last year of life, followed by the initial and continuing phases (medical services: $109,727, $43,516, and $5,518, and oral prescription drugs: $4,372, $1,874, $1,041, respectively). The differences in national costs reflect prevalence of the disease, treatment patterns, and costs for different types of care for the different cancer sites. National oral prescription drug costs were highest for those diagnosed with female breast, leukemia, lung, and prostate cancers. National medical services costs were largest for those diagnosed with female breast, colorectal, lung, and prostate cancers and non-Hodgkin lymphomas. These cost estimates include cancer-attributable costs for medical services and oral prescription drugs. dollars), an increase of 10 percent that is only due to the aging and growth of the U.S. Assuming constant future costs, we project costs to be $208.9 billion in 2020 (2020 U.S. National costs for cancer care were estimated to be $190.2 billion in 2015. The national cancer-attributed medical care costs in the United States are substantial and projected to increase due to population changes alone, according to the Medical Care Costs Associated with Cancer Survivorship in the United States article, published in the journal Cancer Epidemiology, Biomarkers & Prevention (1). UV Exposure and Sun-Protective Behavior.Red Meat and Processed Meat Consumption.Medicaid Insurance Coverage of Tobacco Cessation Treatments.
0 kommentar(er)
